This resource offers information on vitamins.

The Australia biologics market reached an estimated USD 7,552.00 million in 2024 and is projected to grow to USD 14,418.49 million by 2033, with a compound annual growth rate of 7.45% between 2025 and 2033.

ACP & Biologics for Pain Management is organized by Empire Medical Training (EMT), Inc in New York City, USA.

Bio-Processing Alliance Inc. offers biologics development and cGMP manufacturing assistance to innovator and service companies. Services include technology transfer.

Biologics are large molecule products used to treat many chronic diseases. Biosimilars are rated as highly similar versions of biologic therapies.

BiologicsCorp, based in Indianapolis, specializes in recombinant protein expression and purification. They provide cytokines, chemokines, growth factors, and viral antigens.

Bioprocess separation membranes are essential to modern biotechnology, ensuring high-purity biologics, efficient production, and scalable, sustainable manufacturing processes.

Lexis Conferences hosts a Biosimilars & Biologics Summit in London, UK.

BiologicsPD.com offers bacterial, baculovirus, insect, yeast, and mammalian cell culture services in a bioreactor.

Master accurate billing of injectable drugs using J-Codes with simple steps, key tips, and outsourcing advice to avoid denials and speed up payments.

Comprehensive Biologics and Dr. Buzz advance healthcare through regenerative medicine. BiologicalMatrix-50, BiologicalMatrix Pro, and BiologicalAmnio are minimally manipulated allografts.

Key factors increasing the orthobiologics market demand are the growing geriatric population, road accidents and sports injuries.

Orthopedic devices are used for restoring skeletal structure and joint movements in various fractures, abnormal growth of bones, soft tissue damage, trauma or other deformities.

BioMarketplace offers life and biotech industries innovative ways to obtain blood, biologics, lab and professional services, and technological products.

Key market growth factors include rising demand for orthobiologics by orthopedic surgeons, to promote faster healing of injuries, and increasing osteoarthritis prevalence.

The global orthobiologics market is expected to reach USD 9.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.31% during 2025-2033 (IMARC Group).

ROS Aesthetics offers biologics treatments for skin, using natural and advanced solutions for rejuvenation, anti-aging, and healing, resulting in youthful skin.

Ritter Implants offers high-quality amniotic membranes to meet the needs of dental professionals, as a leading supplier of dental amniotic biologics.

Skyler Bloom, who holds a Bachelor of Arts in Finance from Southern Methodist University, joined Sphera as an Analyst in June 2015. He is based in the firm’s New York office, covering large-cap companies. Previously, he worked in a family office investment team focusing on therapeutics equities.

Market research projects that the South Korea biologics market will grow at a compound annual growth rate (CAGR) of 7.06%.

The spine biologics market is growing due to increasing spinal fusion procedures. Current trends include rising use of bone grafts and cell-based therapies.

The global biologics contract manufacturing market is projected to exceed $19 billion, with an estimated compound annual growth rate of approximately 9% during the forecast period.